CHRISTINE FARRELL

CIK 1200160 · Chief Financial Officer · last filed 2024-07-16

CHRISTINE FARRELL is a Chief Financial Officer who has filed 35 SEC Form 4 insider transactions across 1 company since 2007. 7 SEC filings were submitted jointly with Odyssey Health, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

35

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

2372 MORSE AVE
IRVINE, CA 92614

Related Filers

Odyssey Health, Inc. — 7 joint filings, latest 2024-07-16

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BIOJECT MEDICAL TECHNOLOGIES INC (BJCT) Delisted	VP of Finance	87,722	—	—	$0	15	2008-06-27

Recent Filings

35 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $
2024-07-16	—	Grant (A)	—	$0
2024-01-02	—	Grant (A)	—	$0
2023-01-13	—	Grant (A)	—	$0
2022-10-19	—	Grant (A)	—	$0
2022-06-08	—	Grant (A)	—	$0
2021-03-01	—	Grant (A)	—	$0
2012-01-04	—	Exer (M)	+25,000	$0
2011-01-04	—	Exer (M)	+39,000	$0
2010-06-11	—	Grant (A)	—	$0
2010-04-26	—	Grant (A)	—	$0

Showing 1–10 of 35

Page 1 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.